文献速递产科母胎医学

自身免疫性皮肤病患者不良妊娠结局风险增加

Patients with autoimmune skin diseases are at increased risk of adverse pregnancy outcomes.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-11-14

基于TriNetX美国协作网络2016年1月1日至2021年12月31日15至44岁孕妇的病例对照研究,将2788例自身免疫性皮肤病患者与2788例健康对照按1:1倾向评分匹配。自身免疫性皮肤病患者自然流产风险高于对照(OR 1.54,95%CI 1.36-1.75,P<.001),其宫内生长受限、早产和死产风险低于系统性红斑狼疮患者,与类风湿关节炎患者无显著差异。

要点

  • 自身免疫性皮肤病患者自然流产风险高于无自身免疫性疾病对照(OR 1.54,95%CI 1.36-1.75,P<.001)。
  • 皮肤型红斑狼疮或白癜风患者自然流产风险仍高于无自身免疫性疾病者。
  • 自身免疫性皮肤病患者不良妊娠结局风险与类风湿关节炎患者相似,低于系统性红斑狼疮患者。

核心结论

  • 自身免疫性皮肤病患者自然流产风险高于无自身免疫性疾病患者。
  • 按具体自身免疫性皮肤病分析,皮肤型红斑狼疮或白癜风患者自然流产风险仍高于无自身免疫性疾病患者。
  • 自身免疫性皮肤病患者不良妊娠结局风险与类风湿关节炎患者相似,但低于系统性红斑狼疮患者。

研究设计与样本

  • 纳入2016年1月1日至2021年12月31日在医疗机构就诊的15至44岁所有孕妇。
  • 自身免疫性皮肤病患者与健康对照及患有系统性风湿病(系统性红斑狼疮或类风湿关节炎)的对照进行匹配。
  • 自身免疫性皮肤病组和健康对照组均排除患有系统性风湿病或化脓性汗腺炎者。
  • 自身免疫性皮肤病患者与对照按年龄、种族、民族、合并症、肥胖和物质使用进行1:1倾向评分匹配,共2788例自身免疫性皮肤病患者匹配2788例健康对照。

主要发现

  • 自身免疫性皮肤病患者自然流产风险高于健康对照(OR 1.54,95%CI 1.36-1.75,P<.001)。
  • 与系统性红斑狼疮患者相比,自身免疫性皮肤病患者宫内生长受限风险更低(OR 0.59,95%CI 0.4-0.87,P=.01)。
  • 与系统性红斑狼疮患者相比,自身免疫性皮肤病患者早产风险更低(OR 0.68,95%CI 0.47-0.98,P=.04)。
  • 与系统性红斑狼疮患者相比,自身免疫性皮肤病患者死产风险更低(OR 0.50,95%CI 0.25-0.97,P=.04)。
  • 自身免疫性皮肤病患者与类风湿关节炎患者的不良妊娠结局差异无统计学意义。

关键数值与推荐

  • 主要结局为不良妊娠结局,定义为自然流产、妊娠期高血压、子痫前期或子痫、妊娠期糖尿病、宫内生长受限、未足月胎膜早破、早产和死产。
  • 自身免疫性皮肤病患者与健康对照比较自然流产:OR 1.54,95%CI 1.36-1.75,P<.001。
  • 自身免疫性皮肤病患者与系统性红斑狼疮患者比较宫内生长受限:OR 0.59,95%CI 0.4-0.87,P=.01。
  • 自身免疫性皮肤病患者与系统性红斑狼疮患者比较早产:OR 0.68,95%CI 0.47-0.98,P=.04。
  • 自身免疫性皮肤病患者与系统性红斑狼疮患者比较死产:OR 0.50,95%CI 0.25-0.97,P=.04。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increased rates of adverse pregnancy outcomes have been reported in association with rheumatologic diseases such as systemic lupus erythematosus, rheumatoid arthritis, dermatomyositis. However, little is known about pregnancy outcomes in patients with autoimmune skin diseases. OBJECTIVE: This study aimed to determine the frequency of adverse pregnancy outcomes in patients with autoimmune skin diseases. We hypothesized that similar to rheumatic diseases, the rate of adverse pregnancy outcomes in patients with autoimmune skin diseases would be higher than the general population. STUDY DESIGN: This is a case control study using the TriNetX US Collaborative Network, which is a database of electronic medical records of >95 million patients seen at 57 healthcare organizations in the United States. All pregnant women between the ages of 15 and 44 years who were seen at a healthcare organization between January 1, 2016 and December 31, 2021 were included. Participants with autoimmune skin disease were matched to healthy controls and controls with systemic rheumatologic conditions (systemic lupus erythematosus or rheumatoid arthritis). For both the autoimmune skin disease and healthy control groups, those with systemic rheumatologic condition or hidradenitis suppurativa were excluded. The primary outcomes were adverse pregnancy outcomes defined as spontaneous abortion, gestational hypertension, preeclampsia or eclampsia, gestational diabetes mellitus, intrauterine growth restriction, preterm premature rupture of membranes, preterm birth, and stillbirth. Patients with autoimmune skin diseases and controls were 1:1 propensity score-matched by age, race, ethnicity, comorbidities, obesity, and substance use. For each outcome, odds ratio with a 95% confidence interval was calculated. RESULTS: A total of 2788 patients with autoimmune skin diseases were matched to 2788 healthy controls. Patients with autoimmune skin diseases were at a higher risk of spontaneous abortions than controls (odds ratio, 1.54; 95% confidence interval, 1.36-1.75; P<.001). Compared with patients with systemic lupus erythematosus, patients with autoimmune skin diseases were at lower risk of having infants with intrauterine growth restriction (odds ratio, 0.59; 95% confidence interval, 0.4-0.87; P=.01), preterm birth (odds ratio, 0.68; 95% confidence interval, 0.47-0.98; P=.04), and stillbirth (odds ratio, 0.50; 95% confidence interval, 0.25-0.97; P=.04). The differences in adverse pregnancy outcomes between patients with autoimmune skin diseases and those with rheumatoid arthritis were not statistically significant. CONCLUSION: Patients with autoimmune skin diseases are at a higher risk of spontaneous abortions than patients without autoimmune skin diseases. When analyzed by each autoimmune skin disease, patients with cutaneous lupus erythematosus or vitiligo remained at increased risk of spontaneous abortions compared with patients without autoimmune skin diseases. Patients with autoimmune skin diseases have similar risks of adverse pregnancy outcomes as patients with rheumatoid arthritis, but lower risks than patients with systemic lupus erythematosus.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Keum H, Bermas B, Patel S, et al. Patients with autoimmune skin diseases are at increased risk of adverse pregnancy outcomes. Am J Obstet Gynecol MFM. 2023. PMID: 37972926. doi:10.1016/j.ajogmf.2023.101226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。